D-Penicillamine in the Neonatal Period: Case Reports
Lajos Lakatos, György Balla, István Pataki, Zsuzsanna Vekerdy-Nagy & György Oroszlán · International Journal of Medical and Pharmaceutical Case Reports · 2015
D-Penicillamine (DPA) was first recognized as a potential benefit for neonatal hyperbilirubinemia (NHBI). During this time there was a remarkedly low incidence of retinopathy of prematurity (ROP) in the infants treated with DPA. Later, our studies were replicated in other institu...
Open access
Research Article
10.9734/IJMPCR/2015/17239